Tamra Judge Criticizes Celebrities For Taking Kim Kardashian Popularized Weight Loss Drug Ozempic: 'I Don't Take Shortcuts'

Tamra Judge, star of the “Real Housewives of Orange County,” recently criticized those who use the weight loss drug Ozempic, popularized by celebrities like Kim Kardashian.

She emphasized the importance of hard work over shortcuts, Page Six reports.

Judge expressed her views in a now-deleted tweet, stating, "There's a difference between skinny and fit…I'm not on Ozempic. I don't take shortcuts."

However, she did not specify who her comments were directed at.

Co-Star Controversy: Her ex-friend and co-star, Jennifer Pedranti, subtly criticized Judge around the time of her tweet on "Watch What Happens Live with Andy Cohen," claiming she was more fit than Judge. Pedranti has not publicly addressed whether she has ever used Ozempic.

See Also: Donald Trump-Owned Truth Social’s Parent Company May Go Public After DWAC Settles Securities Fraud

Other Stars’ Stances: Another co-star, Emily Simpson, admitted to using Ozempic for a month to “kickstart” her weight loss journey but stopped due to feeling “lethargic.” She later underwent liposuction and a breast reduction, and has been vocal about her healthier eating habits.

Judge joins celebrities like Kyle Richards, Garcelle Beauvais, and Gina Kirschenheiter who have denied using the diabetes drug.

Read Next: Ross Gerber Says Tesla Is Like Apple 15 Years Ago, But Better

Image via Shutterstock


Engineered by Benzinga Neuro, Edited by Pooja Rajkumari


The GPT-4 Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EntertainmentNewsHealth CareMediaGeneralhealth careOzempicThe Real Housewivesweightloss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...